Crescita Therapeutics Inc. (TSX:CTX)
Canada · Delayed Price · Currency is CAD 0.7900
0.00 (0.00%)
Inactive · Last trade price on Jun 4, 2026
Crescita Therapeutics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 23.22 | 21.12 | 19.58 | 17.52 | 23.53 | 16.77 | |
Revenue Growth (YoY) | 28.13% | 7.85% | 11.74% | -25.52% | 40.29% | 7.22% |
Cost of Revenue | 11.21 | 10.01 | 10.59 | 7.16 | 10.34 | 6.76 |
Gross Profit | 12.01 | 11.11 | 8.99 | 10.36 | 13.18 | 10.01 |
Selling, General & Admin | 12.01 | 10.82 | 10.81 | 10.12 | 10.57 | 8.72 |
Depreciation & Amortization Expenses | 0.58 | 0.74 | 0.75 | 1.51 | 1.47 | 1.38 |
Research & Development | 0.58 | 0.57 | 0.65 | 0.7 | 0.61 | 0.63 |
Total Operating Expenses | 13.17 | 12.13 | 12.21 | 12.32 | 12.65 | 10.73 |
Operating Income | -1.17 | -1.02 | -3.22 | -1.96 | 0.53 | -0.72 |
Interest Income | 0.29 | 0.33 | 0.5 | 0.51 | 0.26 | 0.18 |
Interest Expense | -0.12 | -0.04 | -0.07 | -0.09 | -0.16 | -0.24 |
Other Non-Operating Income (Expense) | -1.09 | -1.13 | 0.1 | -0.02 | -0.13 | 0.25 |
Total Non-Operating Income (Expense) | -0.91 | -0.84 | 0.53 | 0.41 | -0.02 | 0.2 |
Pretax Income | -0.7 | -0.08 | -2.76 | -1.53 | 0.4 | -1.01 |
Provision for Income Taxes | 0.01 | 0.01 | -0.01 | 0.46 | -0.46 | 0.1 |
Net Income | -0.71 | -0.09 | -2.75 | -1.99 | 0.86 | -1.11 |
Earnings From Discontinued Operations | 1.47 | 1.47 | - | - | - | - |
Net Income to Common | -0.32 | -0.09 | -2.75 | -1.99 | 0.86 | -1.11 |
Shares Outstanding (Basic) | 19 | 19 | 19 | 20 | 21 | 21 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 20 | 21 | 21 |
Shares Change (YoY) | -2.28% | -2.61% | -4.44% | -3.55% | 1.18% | -1.02% |
EPS (Basic) | -0.02 | - | -0.14 | -0.10 | 0.04 | -0.05 |
EPS (Diluted) | -0.02 | - | -0.14 | -0.10 | 0.04 | -0.05 |
Free Cash Flow | 1.49 | 0.74 | 1.54 | 1.94 | -1.25 | -1.94 |
Free Cash Flow Growth | 101.89% | -51.95% | -20.74% | - | - | - |
Free Cash Flow Per Share | 0.08 | 0.04 | 0.08 | 0.10 | -0.06 | -0.09 |
Gross Margin | 51.71% | 52.60% | 45.91% | 59.15% | 56.03% | 59.72% |
Operating Margin | -5.02% | -4.84% | -16.42% | -11.16% | 2.25% | -4.29% |
Profit Margin | -3.06% | -0.44% | -14.04% | -11.33% | 3.66% | -6.59% |
FCF Margin | 6.43% | 3.50% | 7.87% | 11.09% | -5.31% | -11.59% |
EBITDA | -0.04 | 0.48 | -1.85 | -0.45 | 2 | 0.66 |
EBITDA Margin | -0.18% | 2.27% | -9.44% | -2.57% | 8.50% | 3.94% |
EBIT | -1.17 | -1.02 | -3.22 | -1.96 | 0.53 | -0.72 |
EBIT Margin | -5.02% | -4.84% | -16.42% | -11.16% | 2.25% | -4.29% |
Effective Tax Rate | -1.28% | -10.84% | 0.51% | -29.80% | -113.37% | -9.51% |